CoMo Pharma

Active Risk: not assessed

General partnershipfounded 2026incorporated this yearWilgendreef 40, 8300 Knokke-Heist, BelgiumKBO/BCE: BE 1039.673.021

Summary

CoMo Pharma is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Risk analysisWatch Report Compare

CoMo PharmaActive

Risk analysis Report Compare

Directors

1 director, no change since 2026

Guy Morel

Non-statutory manager · since 03-07-2026

Current

Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →

Mandate history

1 person since 2026, 1 in office

All 1 In office 1

Board

Mandates per person, with start and end dates
Name	Functions and periods
Guy Morel	Non-statutory manager, from 03-07-2026 to date

See the board, name and seat on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the acts

At incorporation act of 03-07-2026 ↗

Hannelore Cocquyt hoofdelijk aansprakelijke vennoot · €5,000 in cash
Guy Morel hoofdelijk aansprakelijke vennoot · €5,000 in cash

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.